Elevated Risk of Premature Ovarian Failure Following Severe Postpartum Hemorrhage Requiring Blood Transfusion: Insights from a Nationwide Korean Cohort

Highlight

This nationwide Korean cohort study finds a strong association between severe postpartum hemorrhage (PPH) treated with blood transfusions and the subsequent risk of premature ovarian failure (POF). The risk increases with greater transfusion volume, highlighting the importance of identifying and monitoring women at high risk.

Study Background

Postpartum hemorrhage remains a leading cause of maternal morbidity and mortality worldwide. Beyond the acute consequences, the long-term impact of severe PPH on women’s reproductive health, particularly ovarian function, has not been extensively studied. Premature ovarian failure, defined as ovarian insufficiency before the age of 40, can significantly impact fertility, hormonal balance, and overall quality of life. Identifying risk factors for POF is critical for early intervention and counseling.

Study Design

This retrospective, population-based cohort study utilized data from the Korean National Health Insurance Service (KNHIS) database, evaluating women who delivered between 2015 and 2016. The cohort included 745,125 women who were followed until a diagnosis of premature ovarian failure, reaching 40 years of age, or December 31, 2021, whichever occurred first.

Postpartum hemorrhage was identified through ICD-10 diagnostic codes, and severity was proxied by the requirement for red blood cell transfusion during delivery hospitalization. POF was defined as ovarian failure diagnosed before the age of 40 years. The primary analysis involved Cox proportional hazards models adjusting for potential confounders to estimate hazard ratios (HRs) for incident POF associated with PPH and transfusion status.

Key Findings

Out of the total cohort, 78,225 women (10.5%) experienced PPH, and 3,552 (0.48%) developed POF during follow-up. The study established a clear difference in POF risk based on severity of haemorrhage indicated by transfusion status:

• Women with PPH requiring red blood cell transfusion demonstrated more than double the risk of POF (adjusted HR 2.058, 95% CI 1.668–2.539; p < 0.0001).
• Women with PPH but no transfusion showed only a borderline, statistically nonsignificant association with POF (adjusted HR 1.108, 95% CI 0.993–1.237; p = 0.066).
• A dose-response relationship was apparent with increasing transfusion volume: adjusted HRs rose progressively from 1.749 for 1 unit, to 2.507 for 2–3 units, and 2.894 for ≥4 units (p < 0.0001), suggesting a gradient of risk linked to PPH severity.

These results suggest that severe blood loss necessitating transfusion during delivery is a strong predictor of subsequent premature ovarian failure.

Expert Commentary

This large-scale, longitudinal investigation provides robust epidemiological evidence linking severe PPH with long-term impairment of ovarian function. The use of transfusion as a proxy for haemorrhage severity is clinically intuitive and strengthens the study’s conclusions. The observed dose-response relationship further supports a likely causal association.

Potential biological mechanisms may include hypovolemia-induced ischemic injury to the ovarian tissue, oxidative stress, or systemic inflammatory responses triggered by blood loss and transfusion, contributing to accelerated follicular depletion. However, the study’s observational nature cannot definitively establish causality, and residual confounding by clinical factors such as underlying coagulopathy or obstetric complications warrants consideration.

These findings align with previous smaller studies that reported associations between severe obstetric bleeding and reproductive sequelae but expand understanding by leveraging comprehensive nationwide data and detailed transfusion data. Clinicians should be aware that women who have experienced transfusion-requiring PPH represent a high-risk group for POF and may benefit from targeted endocrine evaluation and reproductive counseling.

Limitations include reliance on administrative codes for PPH and POF diagnosis, which may be subject to misclassification, and lack of granular clinical data on causes of hemorrhage or transfusion timing. Ethnic and healthcare system factors may affect generalizability beyond Korean populations.

Conclusion

Severe postpartum hemorrhage requiring blood transfusion is independently associated with a substantially increased risk of premature ovarian failure. The findings emphasize the need for long-term endocrine and reproductive health surveillance in women surviving severe PPH. Future research should explore preventive strategies and elucidate the biological mechanisms to mitigate ovarian injury after obstetric hemorrhage. Clinicians should incorporate this risk into postpartum care planning and patient counseling to optimize reproductive outcomes.

Funding and ClinicalTrials.gov

The study was supported by the Korean National Health Insurance Service database; specific funding sources were not detailed. The study design was retrospective cohort analysis, not registered in a clinical trials database.

References

1. Kim MA, Son JH, Seol HJ, Oh MJ, Cho GJ, Kim YH. Association Between Blood Transfusion for Postpartum Haemorrhage and the Risk of Premature Ovarian Failure: A Nationwide Population-Based Cohort Study. BJOG. 2026 Aug 4. PMID: 42549981.

2. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168-e186.

3. Sullivan SD, Castracane VD. Premature Ovarian Failure: A Review. Curr Opin Endocrinol Diabetes Obes. 2015;22(6):563-569.

4. Practice Committee of the ASRM. Premature ovarian insufficiency. Fertil Steril. 2020;113(5):1002-1013.